Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 776

    1.

    Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.

    Giugliano D, Acampora R, Marfella R, De Rosa N, Ziccardi P, Ragone R, De Angelis L, D'Onofrio F.

    Ann Intern Med. 1997 Jun 15;126(12):955-9.PMID: 9182472 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

    Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Wright JT Jr, Oakes R, Lukas MA, Anderson KM, Bell DS; GEMINI Investigators.

    JAMA. 2004 Nov 10;292(18):2227-36.PMID: 15536109 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.

    Bell DS, Bakris GL, McGill JB.

    Diabetes Obes Metab. 2009 Mar;11(3):234-8. Epub 2008 Jun 17.PMID: 18564334 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

    Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, Camel G, Davis BR, Frost PH, Gonzalez N, Guthrie G, Oberman A, Rutan GH, Stamler J.

    JAMA. 1996 Dec 18;276(23):1886-92. Erratum in: JAMA 1997 May 7;277(17):1356. PMID: 8968014 [PubMed - indexed for MEDLINE]Related articles

    6.

    Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes.

    Fogari R, Zoppi A, Lazzari P, Mugellini A, Lusardi P, Preti P, Van Nueten L, Vertommen C.

    J Hum Hypertens. 1997 Nov;11(11):753-7.PMID: 9416986 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.

    Giugliano D, Marfella R, Acampora R, Giunta R, Coppola L, D'Onofrio F.

    Diabetes Care. 1998 Apr;21(4):631-6.PMID: 9571355 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.

    Ruilope LM.

    Am J Hypertens. 1994 Feb;7(2):129-36. Erratum in: Am J Hypertens 1994 Apr;7(4 Pt 1):379. PMID: 7910028 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of bunazosin and atenolol on glucose metabolism in obese, nondiabetic patients with primary hypertension.

    Bönner G, Schmieder R, Chrosch R, Weidinger G.

    Cardiovasc Drugs Ther. 1997 Mar;11(1):21-6.PMID: 9140673 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial.

    Toft I, Bønaa KH, Ingebretsen OC, Nordøy A, Jenssen T.

    Ann Intern Med. 1995 Dec 15;123(12):911-8.PMID: 7486485 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The effect of carvedilol on metabolic parameters in patients with metabolic syndrome.

    Uzunlulu M, Oguz A, Yorulmaz E.

    Int Heart J. 2006 May;47(3):421-30.PMID: 16823248 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    [The effects of bisoprolol and atenolol on glucose metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus]

    Vulpis V, Antonacci A, Prandi P, Bokor D, Pirrelli A.

    Minerva Med. 1991 Apr;82(4):189-93. Italian. PMID: 1673233 [PubMed - indexed for MEDLINE]Related articles

    16.

    Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects.

    Feher MD, Henderson AD, Wadsworth J, Poulter C, Gelding S, Richmond W, Sever PS, Elkeles RS.

    J Hum Hypertens. 1990 Oct;4(5):571-7.PMID: 1980930 [PubMed - indexed for MEDLINE]Related articles

    17.

    Metabolic effects of carvedilol in hypertensive patients.

    Lithell H, Andersson PE.

    Eur J Clin Pharmacol. 1997;52(1):13-7.PMID: 9143861 [PubMed - indexed for MEDLINE]Related articles

    18.

    Insulin sensitivity in hypertensive Type 2 diabetic patients after 1 and 19 days' treatment with trandolapril.

    New JP, Bilous RW, Walker M.

    Diabet Med. 2000 Feb;17(2):134-40.PMID: 10746484 [PubMed - indexed for MEDLINE]Related articles

    19.

    How safe is carvedilol in NIDDM patients with hypertension?

    Choudhury D, Misra A.

    Natl Med J India. 1998 May-Jun;11(3):130-1. No abstract available. PMID: 9707705 [PubMed - indexed for MEDLINE]Related articles

    20.

    Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients.

    Jordan J, Engeli S, Boschmann M, Weidinger G, Luft FC, Sharma AM, Kreuzberg U.

    J Hypertens. 2005 Dec;23(12):2313-8.PMID: 16269974 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data